Changes of lipidic and the immunological state at patients with a metabolic syndrome in Ukraine.
Autor: | Karlova OO; National Medical Academy Of Postgraduate Education Named P.L.Shupyk, Kyiv, Ukraine., Omelchuk ST; A.A. Bogomolets National Medical University, Kyiv, Ukraine., Kuzminska OV; A.A. Bogomolets National Medical University, Kyiv, Ukraine., Melnyk VV; A.A. Bogomolets National Medical University, Kyiv, Ukraine. |
---|---|
Jazyk: | angličtina |
Zdroj: | Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2017; Vol. 70 (2), pp. 221-223. |
Abstrakt: | Introduction: The metabolic syndrome has become pandemic nature and tends to rejuvenation in the world. Elucidation of the pathogenic mechanisms on membrane-cell level will optimize the treatment of patients with metabolic syndrome and prevention of metabolic syndrome on the level of pre-clinical manifestations. Aim: to study the immunological status and lipid metabolism in the patients with metabolic syndrome and the pathogenetic mechanisms of metabolic syndrome were established. Material and Methods: There were 4 groups of pacients (110) with: metabolic syndrome, ischemic heart disease and hypertension, hypertention; control group. General clinical, instrumental, laboratory and statistical methods were used. Results: The levels of immune factors - interleukin-6 in supernatants of mononuclear cells by 65%, sICAM-1 by 20% is elevated in patients with metabolic syndrome compared with the control group. The increasing of the content of saturated fatty acids by 9.4% and polyunsaturated fatty acid by 36.6% lead to fundamental breach of structural and functional properties of membranes. There is significant common carotid artery intima media thickness on average twice at the patients with metabolic syndrome and with ischemic heart disease and hypertension. Conclusions: The immunoinflammatory reactions were more revealed in the group of patients with metabolic syndrome than in other groups. The lipid state at patients with metabolic syndrome was changed more than in patients with hypertension or patients with ischemic heart disease and hypertension both. Moreover our data indicate the presence of structural changes in the vessel wall in patients with metabolic syndrome. |
Databáze: | MEDLINE |
Externí odkaz: |